Endothelial damage and regeneration: The role of the renin-angiotensin- aldosterone system

Current Hypertension Reports

Volumn 13, Issue 1, 2011, Pages 86-92

  Becher, Ulrich M ^a   Endtmann, Cathleen ^a   Tiyerili, Vedat ^a   Nickenig, Georg ^a   Werner, Nikos ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

ACE inhibitor; Ang II; Angiotensin II; Angiotensin II receptor blocker; Angiotensin converting enzyme inhibitor; ARB; Atherosclerosis; Direct renin inhibitor; DRI; Endothelial damage; Endothelial dysfunction; Endothelial progenitor cells; Endothelial regeneration; EPC; Renin angiotensin aldosterone system (RAAS)

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ALISKIREN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPLERENONE; MATRIX METALLOPROTEINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RAMIPRIL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RENIN INHIBITOR; SPIRONOLACTONE; STAT PROTEIN; TELMISARTAN; VASCULOTROPIN RECEPTOR 2;

ANEMIA; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL REGENERATION; DRUG RECEPTOR BINDING; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; HEART PROTECTION; HEMATOCRIT; HEMATOPOIETIC STEM CELL; HUMAN; HYPERTENSION; LEUKOPENIA; NONHUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIDE EFFECT; VASCULAR ENDOTHELIUM;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; REACTIVE OXYGEN SPECIES; RENIN; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; STEM CELLS;

EID: 79551536252     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-010-0171-x     Document Type: Article

References (52)

1. S Wassmann G Nickenig 2006 Pathophysiological regulation of the AT1-receptor and implications for vascular disease J Hypertens Suppl 24 S15 S21 1:CAS:528:DC%2BD28Xjt1Cltr0%3D 10.1097/01.hjh.0000220402.53869.72 16601568 (Pubitemid 44336819)
2. R Ross 1999 Atherosclerosis-an inflammatory disease N Engl J Med 340 115 126 1:STN:280:DyaK1M%2FptFSqtQ%3D%3D 10.1056/NEJM199901143400207 9887164 (Pubitemid 29054847)
3. Y Suzuki M Ruiz-Ortega O Lorenzo, et al. 2003 Inflammation and angiotensin II Int J Biochem Cell Biol 35 6 881 900 1:CAS:528: DC%2BD3sXisFShu70%3D 10.1016/S1357-2725(02)00271-6 12676174 (Pubitemid 36379329)
4. M Sata D Fukuda 2010 Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis J Med Invest 57 1-2 12 25 10.2152/jmi.57.12 20299739 This review reports on the critical role of Ang II in the initiation and progression of atherosclerosis
5. A Warnholtz G Nickenig E Schulz, et al. 1999 Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system Circulation 99 15 2027 33 1:CAS:528:DyaK1MXivFSrsbk%3D 10209008
6. F Marino L Guasti M Cosentino, et al. 2008 Simvastatin treatment in subjects at high cardiovascular risk modulates AT1R expression on circulating monocytes and T lymphocytes J Hypertens 26 6 1147 55 1:CAS:528: DC%2BD1cXlslGlsLs%3D 10.1097/HJH.0b013e3282f97dde 18475152 (Pubitemid 351670506)
7. YX Wang 2005 Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice Neurobiol Aging 26 3 309 16 1:CAS:528:DC%2BD2MXitVejsQ%3D%3D 10.1016/j.neurobiolaging.2004.06.018 15639308 (Pubitemid 40082713)
8. C Urbich S Dimmeler 2005 Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors Kidney Int 67 5 1672 6 1:CAS:528:DC%2BD2MXktlOqtbY%3D 10.1111/j.1523-1755.2005.00261.x 15840010 (Pubitemid 40577698)
9. Endtmann C, Ebrahimian T, Bohner A, et al. Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration [abstract V617]. Presented at the DGK Congress. Mannheim, Germany; April 8-10, 2010.
10. KE Herbert Y Mistry R Hastings, et al. 2008 Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways Circ Res 102 2 201 8 1:CAS:528:DC%2BD1cXhtVGktLY%3D 10.1161/CIRCRESAHA.107.158626 17991883 (Pubitemid 351651124)
11. FH Seeger D Sedding AC Langheinrich, et al. 2010 Inhibition of the p38 MAP kinase in vivo improves number and functional activity of vasculogenic cells and reduces atherosclerotic disease progression Basic Res Cardiol 105 3 389 97 1:CAS:528:DC%2BC3cXis1yhsb8%3D 10.1007/s00395-009-0072-9 19911112
12. LJ Min M Mogi J Iwanami JM Li, et al. 2008 Angiotensin II type 2 receptor deletion enhances vascular senescence by methyl methanesulfonate sensitive 2 inhibition Hypertension 51 5 1339 44 1:CAS:528:DC%2BD1cXktlylsLg%3D 10.1161/HYPERTENSIONAHA.107.105692 18362223 (Pubitemid 351555947)
13. M Pirro G Schillaci F Bagaglia, et al. 2008 Microparticles derived from endotheial progenitor cells in patients at different cardiovascular risk Atherosclerosis 197 757 67 1:CAS:528:DC%2BD1cXktFCktrY%3D 10.1016/j. atherosclerosis.2007.07.012 17720166 (Pubitemid 351417873)
14. T Asahara T Murohara A Sullivan, et al. 1997 Isolation of putative progenitor endothelial cells for angiogenesis Science 275 5302 964 7 1:CAS:528:DyaK2sXht1Clu7k%3D 10.1126/science.275.5302.964 9020076 (Pubitemid 27087709)
15. T Asahara H Masuda T Takahashi, et al. 1999 Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization Circ Res 85 221 228 1:CAS:528:DyaK1MXltFGgs7Y%3D 10436164
16. M Peichev AJ Naiyer D Pereira, et al. 2000 Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors Blood 95 3 952 8 1:CAS:528:DC%2BD3cXotV2gsA%3D%3D 10648408
17. DN Prater J Case DA Ingram MC Yoder 2007 Working hypothesis to redefine endothelial progenitor cells Leukemia 21 6 1141 9 1:CAS:528:DC%2BD2sXlsFOhs78%3D 10.1038/sj.leu.2404676 17392816 (Pubitemid 46831802)
18. MC Yoder 2009 Defining human endothelial progenitor cells J Thromb Haemost 7 Suppl 1 49 52 1:CAS:528:DC%2BD1MXpvV2jur8%3D 10.1111/j.1538-7836.2009. 03407.x 19630767
19. PJ Critser MC Yoder 2010 Endothelial colony-forming cell role in neoangiogenesis and tissue repair Curr Opin Organ Transplant 15 1 68 72 10.1097/MOT.0b013e32833454b5 19898235
20. J Hur CH Yoon HS Kim, et al. 2004 Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis Arterioscler Thromb Vasc Biol 24 2 288 93 1:CAS:528: DC%2BD2cXnsFCgsQ%3D%3D 10.1161/01.ATV.0000114236.77009.06 14699017 (Pubitemid 38197580)
21. DP Sieveking A Buckle DS Celermajer MK Ng 2008 Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay J Am Coll Cardiol 51 6 660 8 1:CAS:528:DC%2BD1cXhslGrtbw%3D 10.1016/j.jacc.2007.09.059 18261686 (Pubitemid 351186872)
22. J Case LE Mead WK Bessler, et al. 2007 Human CD34∈+∈AC133∈ +∈VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors Exp Hematol 35 7 1109 18 1:CAS:528:DC%2BD2sXmvVOgsr8%3D 10.1016/j.exphem.2007.04.002 17588480 (Pubitemid 46921310)
23. E Elsheikh M Uzunel Z He, et al. 2005 Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity Blood 106 7 2347 55 1:CAS:528:DC%2BD2MXhtVKqt7zM 10.1182/blood-2005-04-1407 15985545 Epub 2005 Jun 28 (Pubitemid 41510806)
24. KK Hirschi DA Ingram MC Yoder 2008 Assessing identity, phenotype, and fate of endothelial progenitor cells Arterioscler Thromb Vasc Biol 28 9 1584 95 1:CAS:528:DC%2BD1cXpvFKhurs%3D 10.1161/ATVBAHA.107.155960 18669889 Epub 2008 Jul 31. Review
25. N Werner G Nickenig 2007 Endothelial progenitor cells in health and atherosclerotic disease Ann Med 39 82 90 1:CAS:528:DC%2BD2sXmtVGrtLs%3D 10.1080/07853890601073429 17453672 (Pubitemid 46598174)
26. RZ Shi JC Wang SH Huang, et al. 2009 Angiotensin II induces vascular endothelial growth factor synthesis in mesenchymal stem cells Exp Cell Res 315 1 10 5 1:CAS:528:DC%2BD1cXhsVOis7%2FM 10.1016/j.yexcr.2008.09.024 18973754
27. JM Hill G Zalos JP Halcox, et al. 2003 Circulating endothelial progenitor cells, vascular function, and cardiovascular risk N Engl J Med 348 593 600 10.1056/NEJMoa022287 12584367 (Pubitemid 36204953)
28. N Werner S Kosiol T Schiegl, et al. 2005 Circulating endothelial progenitor cells and cardiovascular outcomes N Engl J Med 353 999 1007 1:CAS:528:DC%2BD2MXpvVOisbw%3D 10.1056/NEJMoa043814 16148285 (Pubitemid 41262334)
29. N Werner S Wassmann P Ahlers, et al. 2007 Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease Basic Res Cardiol 102 565 571 10.1007/s00395-007-0680-1 17932708 (Pubitemid 47578401)
30. Cheng S, Cohen KS, Shaw SY, et al. Association of Colony-Forming Units with Coronary Artery and Abdominal Aortic Calcification. Circulation. 2010 Sep 7 (Epub ahead of print).
31. MC Yoder LE Mead D Prater, et al. 2007 Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals Blood 109 5 1801 9 1:CAS:528:DC%2BD2sXjtFeqtrc%3D 10.1182/blood-2006-08-043471 17053059 (Pubitemid 46348173)
32. W Rosamond K Flegal G Friday 2007 Heart and stroke statistics 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 115 e69 e171 10.1161/CIRCULATIONAHA. 106.179918 17194875 (Pubitemid 46226160)
33. JF Mann RE Schmieder M McQueen, et al. 2008 ONTARGET investigators. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial Lancet 372 9638 547 53 1:CAS:528:DC%2BD1cXpvFKgsLs%3D 10.1016/S0140-6736(08) 61236-2 18707986 This trial analyzed whether ARBs and ACE inhibitors in combination might be more effective than either treatment alone in people at high vascular risk. Although combination therapy reduced proteinuria to a greater extent than monotherapy, the combination worsens major outcomes overall
34. HOPE Study Organisation 2000 Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators Lancet 355 9200 253 9 10.1016/S0140-6736(99)12323-7 (Pubitemid 30068516)
35. C Qian RG Schoemaker WH van Gilst AJ Roks 2009 The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function Clin Sci (Lond) 116 4 301 14 1:CAS:528:DC%2BD1MXlsFKnsQ%3D%3D 10.1042/CS20080157 This is a state-of-the-art review focusing on regenerative progenitor cell therapy with respect to the role of the RAAS
36. FH Bahlmann K de Groot O Mueller, et al. 2005 Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists Hypertension 45 4 526 9 1:CAS:528:DC%2BD2MXisVGksr0%3D 10.1161/01.HYP.0000159191.98140.89 15767470 (Pubitemid 40411254)
37. Y Yu N Fukuda EH Yao, et al. 2008 Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension Am J Hypertens 21 72 77 1:CAS:528:DC%2BD1cXisVOgtbg%3D 10.1038/ajh.2007.5 18091747
38. P Müller A Kazakov P Jagoda, et al. 2009 ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload Cardiovasc Res 83 1 106 14 10.1093/cvr/cvp123 19380417
39. FM Rauscher PJ Goldschmidt-Clermont BH Davis, et al. 2003 Aging, progenitor cell exhaustion, and atherosclerosis Circulation 108 457 463 10.1161/01.CIR.0000082924.75945.48 12860902 (Pubitemid 36935540)
40. A Honda K Matsuura N Fukushima, et al. 2009 Telmisartan induces proliferation of human endothelial progenitor cells via PPARγ-dependent PI3K/Akt pathway Atherosclerosis 205 2 376 84 1:CAS:528:DC%2BD1MXptVemtbs%3D 10.1016/j.atherosclerosis.2008.12.036 19193378 This paper investigates the effects of telmisartan on endothelial integrity and vasculogenesis
41. DZ Cherney V Lai JW Scholey, et al. 2010 Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study Diabetes Care 33 2 361 5 1:CAS:528:DC%2BC3cXitlaltrk%3D 10.2337/dc09-1303 19889802
42. H Lu DL Rateri RJ Feldman DL Jr, et al. 2008 Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice J Clin Invest 118 3 984 93 1:CAS:528:DC%2BD1cXivFems7Y%3D 18274671
43. JH van Esch E Moltzer R van Veghel, et al. 2010 Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats J Hypertens 28 10 2145 55 20625318
44. R Negro 2008 Endothelial effects of antihypertensive treatment: focus on irbesartan Vasc Health Risk Manag 4 1 89 101 1:CAS:528:DC%2BD1cXkslKqu7Y%3D 10.2147/vhrm.2008.04.01.89 18629353 (Pubitemid 351460850)
45. FA Martinez 2010 Aldosterone Inhibition and Cardiovascular Protection: More Important Than it Once Appeared Cardiovasc Drugs Ther 24 4 345 50 1:CAS:528:DC%2BC3cXhtFyju7zM 10.1007/s10557-010-6256-6 20676926
46. T Marumo H Uchimura M Hayashi, et al. 2006 Aldosterone impairs bone marrow-derived progenitor cell formation Hypertension 48 490 496 1:CAS:528:DC%2BD28XnvFKqu7w%3D 10.1161/01.HYP.0000235681.25685.cf 16847146 (Pubitemid 44253745)
47. A Verhovez A Zeoli TA Williams, et al. 2008 Primary aldosteronism and endothelial progenitor cell bioavailability Clin Endocrinol 69 528 34 1:CAS:528:DC%2BD1cXht1KqtLjM 10.1111/j.1365-2265.2008.03271.x
48. • Thum T, Schmitter K, Fleissner F, et al. Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans. Eur Heart J 2010 Oct 5 (Epub ahead of print). This paper demonstrates the effect of aldosterone on endothelial progenitor cell number and function in mice and humans.
49. IC Haznedaroglu MA Ozturk 2003 Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system Int J Biochem Cell Biol 35 867 80 1:CAS:528:DC%2BD3sXisFShu7w%3D 10.1016/S1357-2725(02)00278-9 12676173 (Pubitemid 36379328)
50. D Tousoulis I Andreou C Antoniades, et al. 2008 Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases Atherosclerosis 201 2 236 47 1:CAS:528:DC%2BD1cXhsVGgsLfO 10.1016/j.atherosclerosis.2008.05.034 18599065
51. H Abali IC Haznedaroglu H Goker, et al. 2002 Circulating and local bone marrow renin-angiotensin system in leukemic hematopoiesis: preliminary evidences Hematology 7 2 75 82 1:CAS:528:DC%2BD38XltlKrsL4%3D 10.1080/10245330290022160 12186695
52. LA Cassis DL Rateri H Lu A Daugherty 2007 Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms Arterioscler Thromb Vasc Biol 27 2 380 6 1:CAS:528:DC%2BD2sXjvFKhtQ%3D%3D 10.1161/01.ATV.0000254680.71485.92 17158350 (Pubitemid 46143055)